Aberrant DNA hypermethylation-regulated long non-coding RNA RYR3-DT affects ferroptosis and progression of glioma cell through the CoQ10/FSP1 axis

2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The RYR3-DT divergent transcript is a long noncoding RNA overexpressed in gliomas. DNA methylation is frequently perceived as a crucial process associated with epigenetic changes and among the preeminent mechanisms involved in gene inactivation. Ferroptosis is a recently discovered class of cell necrosis and death. Ferroptosis stimulation can potentially eliminate malignancies. RYR3-DT expression and its exact mechanism in glioma remain ambiguous. This investigation found that RYR3-DT was markedly elevated in gliomas. In-vitro functional assays, including Transwell assay, CCK-8, Western blot, and Annexin V assay, revealed that RYR3-DT silencing inhibits glioma cells growth, migration, and invasion, while stimulated cellular apoptosis. Western blot analysis and RNA sequencing proved that RYR3-DT regulated the ferroptosis CoQ10/FSP1 pathway, concluding that lncRNA RYR3-DT deletion might suppress glioma cell growth migrating and invading ability, and also increase cellular apoptosis via CoQ10/FSP1 pathway. Our research recommends lncRNA RYR3-DT is an expected target for future discoveries on glioma treatment.

Cite

CITATION STYLE

APA

Cui, Y. (2025). Aberrant DNA hypermethylation-regulated long non-coding RNA RYR3-DT affects ferroptosis and progression of glioma cell through the CoQ10/FSP1 axis. Discover Oncology, 16(1). https://doi.org/10.1007/s12672-025-03115-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free